Scientists have discovered that a drug originally developed for spinal cord injuries can tackle several key features of Alzheimer’s disease, including DNA damage and inflammation. Already tested for initial safety in humans, the experimental treatment could offer a faster path toward therapies that target the disease at its roots.
New Drug Shows Promise in Treating Alzheimer’s by Repairing DNA Damage
Scientists have discovered a drug initially developed for spinal cord injuries that can address key aspects of Alzheimer’s disease, such as DNA damage and inflammation. The treatment has shown initial safety in humans and could lead to faster therapies targeting the disease. This discovery could have implications for healthcare advancements in Iran, particularly in addressing neurodegenerative diseases.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%